1. Home
  2. Live Updates
  3. Covid drug

Live Breaking News & Updates on Covid drug

Stay informed with the latest breaking news from Covid drug on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covid drug and stay connected to the pulse of your community

Donald Trump's 'miracle drug' for COVID killed nearly 17,000 people: Study

A new study by French researchers has found that nearly 17,000 people across six countries may have died after being prescribed hydroxychloroquine during COVID.

Turkey , Italy , Spain , France , Belgium , United-states , Americans , French , Donald-trump , Drug-administration , New-england-journal , Covid-19

US FDA approves Pfizer's Covid antiviral pill Paxlovid for high-risk adults

Paxlovid is the fourth drug and and first oral antiviral pill approved by the FDA to treat COVID-19 in adults.

China , Patrizia-cavazzoni , Joe-biden , Anthony-fauci , Seagen-inc , Pfizer , New-covid , President-joe-biden , Wall-street , New-york-based , Us-fda , Oral-antiviral-pill

The newest and best COVID treatment is the one you can't get

COVID-19 hospitalizations totaled around 40,000 and deaths were over 400 per day as of Feb. 10. (Case numbers are unreliable because testing has decreased and, anyway, so many positives go unreported.) Thus, we still need treatments.

United-states , Canada , Brazil , American , Drug-administration , Eiger-biopharmaceuticals-inc , Office-of-biotechnology , Emergency-use-authorization , New-england-journal , Covid , Covid-drug

Japan gives emergency approval to Shionogi's oral COVID-19 drug

Japan's health ministry grants fast-track approval to Shionogi & Co.'s oral COVID-19 drug, making it the country's first domestically-produced oral medicine against the virus.

Tokyo , Japan , Vietnam , Republic-of , Iwate , South-korea , Japanese , Katsunobu-kato , Shionogi-co , Pfizer-inc , Merck-co , Devices-agency

Drug cos recording profits; COVID treatment still out of reach for poor: WHO

Even as Covid drug makers are posting record profits, the lifesaving treatments often remain out of reach for the poor, the World Health Organisation said.

Tedros-adhanom-ghebreyesus , Pfizer , World-health-organisation , Bill-gates-warns , Deadlier-coronavirus-pandemic-will-come , Covid-drug , World-health-organization , Covid-19 , Treatments ,

Pfizer to send 7 lakh units of COVID drug Paxlovid to Taiwan

Health Minister Chen Shih-chung said the pills ordered would be enough to cover 3 percent of Taiwan's population, with half of them due to arrive in the second quarter this year.

Taiwan , Taipei , T-ai-pei , United-kingdom , Chen-shih-chung , Pfizer-inc , Minister-chen-shih-chung , Pfizer , Pfizer-news , Covid-19 , Caronavirus

Nasal spray being tested for Covid prevention in future: SaNOtize's Gilly Regev

Multiple variants and waves of Covid-19 have shown vaccines alone won’t be enough to control the virus, underlining the need for other treatments against it.

India , Canada , Israel , Gilly-regev , Regulatory-agency-kingdom , European-union , Health-canada , Drugs-controller-general , Southeast-asian , Regulatory-agency , United-kingdom , Covid-nasal-spary-

Pfizer COVID pill for high-risk patients get EU drug regulator nod

New Delhi: The European Union's drug regulator on Thursday gave the green light to Pfizer Inc's antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost...

Germany , Italy , United-states , Belgium , Karl-lauterbach , Stella-kyriakides , Albert-bourla , Pfizer , European-medicines-agency , European-commission , Chief-executive-albert-bourla , Health-minister-karl-lauterbach

Lupin launches COVID-19 drug Molnupiravir in India

The drug has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult patients with COVID-19 and the ones who have a high risk of progression of the disease including hospitalisation.

South-africa , Mumbai , Maharashtra , India , United-kingdom , Rajeev-sibal , Asia-pacific , Drug-administration , Regulatory-agency , Drug-controller-general , United-kingdom-medicines , Region-formulations

COVID-19 antiviral drug Molnupiravir has 'major safety concerns', says ICMR chief

Addressing a media briefing on Wednesday Dr Balram Bhargava said the pill is not included in the treatment guidelines of the COVID-19 national task force, nor has it been endorsed for treatment by the WHO and the UK.

India , United-kingdom , Mansukh-mandaviya , Balram-bhargava , Union-health , Indian-council-for-medical-research , World-health-organization , Indian-council , Medical-research , Wednesday-dr-balram-bhargava , Drugs-controller-general , Health-minister-mansukh-mandaviya